Journal of Medicinal Chemistry · 2022 · 10 citations · 58 references
Life SciencesMedicinal ChemistryPharmacologyAntimicrobial ResistanceAntimicrobial StewardshipDrug DiscoveryAntibacterial PharmacologyAntibacterial PharmacotherapyAntibacterial ResistanceAntibiotic ResistanceMultidrug ResistanceResistance In Gram-positive BacteriaAntibiotic DiscoveryBacterial Multidrug ResistanceGram-positive Bacterial InfectionsMultidrug-resistant OrganismsNovel Antibacterial Drug DiscoveryQuinolone Resistance MechanismsResistance In Clinical IsolatesResistance Mechanisms In Gram-positive Bacteria
Nosocomial infections caused by resistant Gram-positive organisms are on the rise, presumably due to a combination of factors including prolonged hospital exposure, increased use of invasive procedures, and pervasive antibiotic therapy. Although antibiotic stewardship and infection control measures are helpful, newer agents against multidrug-resistant (MDR) Gram-positive bacteria are urgently needed. Here, we describe our efforts that led to the identification of 5-amino-4-quinolone 111 with exceptionally potent Gram-positive activity with minimum inhibitory concentrations (MICs) ≤0.06 μg/mL against numerous clinical isolates. Preliminary mechanism of action and resistance studies demonstrate that the 5-amino-4-quinolones are bacteriostatic, do not select for resistance, and selectively disrupt bacterial membranes. While the precise molecular mechanism has not been elucidated, the lead compound is nontoxic displaying a therapeutic index greater than 500, is devoid of hemolytic activity, and has attractive physicochemical properties (clog P = 3.8, molecular weight (MW) = 441) that warrant further investigation of this promising antibacterial scaffold for the treatment of Gram-positive infections.
58
Catherine Liu, Arnold S. Bayer, Sara E. Cosgrove et al. · Clinical Infectious Diseases · 2011 · 4.2K citations · Full text
Alicia Hidrón, Jonathan R. Edwards, Jean B. Patel et al. · Infection Control and Hospital Epidemiology · 2008 · 3.8K citations
Drug Solubility: Importance and Enhancement Techniques
Ketan T. Savjani, Anuradha Gajjar, Jignasa Savjani · ISRN Pharmaceutics · 2012 · 2K citations · Full text
"Celbenin" - resistant Staphylococci
M. P. Jevons · BMJ · 1961 · 1.7K citations · Full text